Market Overview:
The global non-opioid pain patches market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic pain, rising geriatric population, and growing demand for non-opioid analgesics. Based on type, the global non-opioid pain patches market is segmented into lidocaine patch, diclofenac patch, methyl salicylate patch, capsaicin patch, ketoprofen patch and others.
Product Definition:
Non-opioid pain patches are adhesive patches that deliver a non-opioid pain reliever, such as lidocaine or capsaicin, directly to the skin. They are often used to treat chronic pain conditions.
Lidocaine Patch:
Lidocaine patch is a transdermal drug-delivery system that uses an adhesive to bind the medication to the skin. Lidocaine patches are used for treating moderate, chronic pain and can be used in combination with other medications. The lidocaine patch works by allowing the active ingredient to diffuse through the skin into the bloodstream and then reaching all areas of pain; thus providing effective relief from non-opioid based pain.
Diclofenac Patch:
Diclofenac patch is a transdermal drug delivery system that contains diclofenac sodium, which is used to treat chronic pain. It’s a non-opioid drug and has been categorized as a non-steroidal anti-inflammatory drug (NSAID). Diclofenac patch works by reducing the production of prostaglandins, which causes pain.
Application Insights:
The market is segmented by application into hospital pharmacies, independent pharmacies and drug stores, online pharmacies, and others. The hospital pharmacy segment dominated the global non-opioid pain patches market in 2017 due to factors such as high usage rates of opioid analgesic drugs for chronic pain conditions. This has resulted in a growing demand for non-opioid based alternatives that are more effective than opioid analgesics.
The independent pharmacy & drug store segment is expected to grow at the fastest rate during the forecast period owing to increasing awareness about alternative treatment options for chronic pain other than opioids. Furthermore, an increase in consumer disposable income levels coupled with rising health consciousness among individuals aged 30 years and above will boost product demand over the forecast period from 2018 to 2030.
Online pharmacies are anticipated to be one of the prominent consumers of these patches due to various advantages they offer including convenience.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing cases of chronic pain and other disorders, rising awareness about OTC products, and presence of key players in the region. Moreover, availability of reimbursement facilities for medical treatments offered by physicians is also one of the major factors driving regional growth.
Asia Pacific is anticipated to be fastest-growing regional market over the forecast period owing to high prevalence of pain conditions coupled with growing healthcare expenditure levels in emerging countries such as China & India. In addition, favorable government initiatives are also expected to drive product demand during this period.
Growth Factors:
- Increasing geriatric population: The global geriatric population is expected to increase from 524 million in 2010 to 1.5 billion by 2050, according to the United Nations Department of Economic and Social Affairs (UNDESA). This growing population is more susceptible to chronic pain, which can be treated with non-opioid pain patches.
- Rising awareness of non-opioid pain patches as an alternative treatment: There is a growing awareness among patients and healthcare professionals about the benefits of using non-opioid pain patches as an alternative treatment for chronic pain. This is driving demand for these products worldwide.
- Technological advancements: The development of new and innovative technologies has helped improve the performance and efficacy of non-opioid pain patches, making them more popular among consumers worldwide.
- Growing number of product approvals: The number of product approvals for non-opioid pain patches has been increasing in recent years, reflecting the growing acceptance of these products by healthcare professionals and consumers alike. This trend is likely to continue in the coming years, boosting growth prospects for this market segment..
Scope Of The Report
Report Attributes
Report Details
Report Title
Non-opioid Pain Patches Market Research Report
By Type
Lidocaine Patch, Diclofenac Patch, Methyl Salicylate Patch, Capsaicin Patch, Ketoprofen Patch, Others
By Application
Hospital Pharmacies, Independent Pharmacies & Drug Stores, Online Pharmacies
By Companies
Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries, Hisamitsu Pharmaceutical, TEH SENG Pharmaceutical, Teikoku Seiyaku, IBSA Institut Biochimque SA, Pfizer, Allergan PLC, Endo International
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
218
Number of Tables & Figures
153
Customization Available
Yes, the report can be customized as per your need.
Global Non-opioid Pain Patches Market Report Segments:
The global Non-opioid Pain Patches market is segmented on the basis of:
Types
Lidocaine Patch, Diclofenac Patch, Methyl Salicylate Patch, Capsaicin Patch, Ketoprofen Patch, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Independent Pharmacies & Drug Stores, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- GlaxoSmithKline
- Johnson & Johnson
- Novartis AG
- Mylan N.V.
- Teva Pharmaceutical Industries
- Hisamitsu Pharmaceutical
- TEH SENG Pharmaceutical
- Teikoku Seiyaku
- IBSA Institut Biochimque SA
- Pfizer
- Allergan PLC
- Endo International
Highlights of The Non-opioid Pain Patches Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Lidocaine Patch
- Diclofenac Patch
- Methyl Salicylate Patch
- Capsaicin Patch
- Ketoprofen Patch
- Others
- By Application:
- Hospital Pharmacies
- Independent Pharmacies & Drug Stores
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Non-opioid Pain Patches Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Non-opioid pain patches are a type of medication that is used to relieve pain. They work by releasing chemicals that block the sensation of pain.
Some of the major players in the non-opioid pain patches market are Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries, Hisamitsu Pharmaceutical, TEH SENG Pharmaceutical, Teikoku Seiyaku, IBSA Institut Biochimque SA, Pfizer, Allergan PLC, Endo International.
The non-opioid pain patches market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Non-opioid Pain Patches Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Non-opioid Pain Patches Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Non-opioid Pain Patches Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Non-opioid Pain Patches Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Non-opioid Pain Patches Market Size & Forecast, 2018-2028
4.5.1 Non-opioid Pain Patches Market Size and Y-o-Y Growth
4.5.2 Non-opioid Pain Patches Market Absolute $ Opportunity
Chapter 5 Global Non-opioid Pain Patches Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Non-opioid Pain Patches Market Size Forecast by Type
5.2.1 Lidocaine Patch
5.2.2 Diclofenac Patch
5.2.3 Methyl Salicylate Patch
5.2.4 Capsaicin Patch
5.2.5 Ketoprofen Patch
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Non-opioid Pain Patches Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Non-opioid Pain Patches Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Independent Pharmacies & Drug Stores
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Non-opioid Pain Patches Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Non-opioid Pain Patches Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Non-opioid Pain Patches Analysis and Forecast
9.1 Introduction
9.2 North America Non-opioid Pain Patches Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Non-opioid Pain Patches Market Size Forecast by Type
9.6.1 Lidocaine Patch
9.6.2 Diclofenac Patch
9.6.3 Methyl Salicylate Patch
9.6.4 Capsaicin Patch
9.6.5 Ketoprofen Patch
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Non-opioid Pain Patches Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Independent Pharmacies & Drug Stores
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Non-opioid Pain Patches Analysis and Forecast
10.1 Introduction
10.2 Europe Non-opioid Pain Patches Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Non-opioid Pain Patches Market Size Forecast by Type
10.6.1 Lidocaine Patch
10.6.2 Diclofenac Patch
10.6.3 Methyl Salicylate Patch
10.6.4 Capsaicin Patch
10.6.5 Ketoprofen Patch
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Non-opioid Pain Patches Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Independent Pharmacies & Drug Stores
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Non-opioid Pain Patches Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Non-opioid Pain Patches Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Non-opioid Pain Patches Market Size Forecast by Type
11.6.1 Lidocaine Patch
11.6.2 Diclofenac Patch
11.6.3 Methyl Salicylate Patch
11.6.4 Capsaicin Patch
11.6.5 Ketoprofen Patch
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Non-opioid Pain Patches Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Independent Pharmacies & Drug Stores
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Non-opioid Pain Patches Analysis and Forecast
12.1 Introduction
12.2 Latin America Non-opioid Pain Patches Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Non-opioid Pain Patches Market Size Forecast by Type
12.6.1 Lidocaine Patch
12.6.2 Diclofenac Patch
12.6.3 Methyl Salicylate Patch
12.6.4 Capsaicin Patch
12.6.5 Ketoprofen Patch
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Non-opioid Pain Patches Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Independent Pharmacies & Drug Stores
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Non-opioid Pain Patches Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Non-opioid Pain Patches Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Non-opioid Pain Patches Market Size Forecast by Type
13.6.1 Lidocaine Patch
13.6.2 Diclofenac Patch
13.6.3 Methyl Salicylate Patch
13.6.4 Capsaicin Patch
13.6.5 Ketoprofen Patch
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Non-opioid Pain Patches Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Independent Pharmacies & Drug Stores
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Non-opioid Pain Patches Market: Competitive Dashboard
14.2 Global Non-opioid Pain Patches Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 GlaxoSmithKline
14.3.3 Johnson & Johnson
14.3.4 Novartis AG
14.3.5 Mylan N.V.
14.3.6 Teva Pharmaceutical Industries
14.3.7 Hisamitsu Pharmaceutical
14.3.8 TEH SENG Pharmaceutical
14.3.9 Teikoku Seiyaku
14.3.10 IBSA Institut Biochimque SA
14.3.11 Pfizer
14.3.12 Allergan PLC
14.3.13 Endo International
